Fatroximin, 100 mg/13,4g, intrauteriinvaht hobustele, kelle liha ei tarvitata inimtoiduks ja veistele
Fatroximin, 100 mg/13,4g, intrauteriinvaht hobustele, kelle liha ei tarvitata inimtoiduks ja veistele
Authorised
- Rifaximin
Product identification
Medicine name:
Fatroximin, 100 mg/13,4g, intrauteriinvaht hobustele, kelle liha ei tarvitata inimtoiduks ja veistele
Active substance:
- Rifaximin
Target species:
-
Horse (non food-producing)
-
Cattle
Route of administration:
-
Intrauterine use
Product details
Active substance and strength:
-
Rifaximin100.00/milligram(s)1.00Container
Pharmaceutical form:
-
Intrauterine foam
Withdrawal period by route of administration:
-
Intrauterine use
-
Horse (non food-producing)
-
Milkno withdrawal periodMitte manustada märadele, kelle liha, söödavaid kudesid ja piima tarvitatakse inimtoiduks.
-
-
Cattle
-
Meat and offal0day
-
Milk0hourPiim: 0 tundi (0 lüpsi).
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG51AA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1107
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 27/01/2022
How useful was this page?:
